These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 362234)

  • 1. Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study.
    Feldman RG; Kelly-Hayes M; Conomy JP; Foley JM
    Neurology; 1978 Nov; 28(11):1094-8. PubMed ID: 362234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of baclofen in treatment of spasticity in multiple sclerosis.
    Sawa GM; Paty DW
    Can J Neurol Sci; 1979 Aug; 6(3):351-4. PubMed ID: 385132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of baclofen in children with cerebral palsy.
    Milla PJ; Jackson AD
    J Int Med Res; 1977; 5(6):398-404. PubMed ID: 338390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis.
    Sachais BA; Logue JN; Carey MS
    Arch Neurol; 1977 Jul; 34(7):422-8. PubMed ID: 327987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.
    Hedley DW; Maroun JA; Espir ML
    Postgrad Med J; 1975 Sep; 51(599):615-8. PubMed ID: 1105499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study.
    Duncan GW; Shahani BT; Young RR
    Neurology; 1976 May; 26(5):441-6. PubMed ID: 772461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen.
    Stien R; Nordal HJ; Oftedal SI; Slettebø M
    Acta Neurol Scand; 1987 Mar; 75(3):190-4. PubMed ID: 3554879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis.
    Eyssette M; Rohmer F; Serratrice G; Warter JM; Boisson D
    Curr Med Res Opin; 1988; 10(10):699-708. PubMed ID: 3286128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baclofen in spasticity.
    Lancet; 1977 Sep; 2(8038):594-5. PubMed ID: 71406
    [No Abstract]   [Full Text] [Related]  

  • 11. Baclofen.
    Young RR
    Arch Neurol; 1977 Nov; 34(11):722. PubMed ID: 911241
    [No Abstract]   [Full Text] [Related]  

  • 12. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis.
    From A; Heltberg A
    Acta Neurol Scand; 1975 Feb; 51(2):158-66. PubMed ID: 1090103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients.
    Hoogstraten MC; van der Ploeg RJ; vd Burg W; Vreeling A; van Marle S; Minderhoud JM
    Acta Neurol Scand; 1988 Mar; 77(3):224-30. PubMed ID: 3376747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonazepam, baclofen and placebo in the treatment of spasticity.
    Cendrowski W; Sobczyk W
    Eur Neurol; 1977; 16(1-6):257-62. PubMed ID: 354938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal baclofen for severe spinal spasticity.
    Penn RD; Savoy SM; Corcos D; Latash M; Gottlieb G; Parke B; Kroin JS
    N Engl J Med; 1989 Jun; 320(23):1517-21. PubMed ID: 2657424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of multiple sclerosis therapy.
    Jaffe R
    Neurology; 1979 May; 29(5):760. PubMed ID: 375123
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities].
    Pellkofer M; Paulig M
    Med Klin (Munich); 1989 Jan; 84(1):5-8. PubMed ID: 2645508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen in the treatment of spasticity.
    Hudgson P; Weightman D
    Br Med J; 1971 Oct; 4(5778):15-7. PubMed ID: 4938243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.